Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19
Background document to the WHO Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
1 June 2021
| COVID-19: Vaccines
Overview
This background document on the Sinovac-CoronaVac vaccine was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations referenced below. This background document was developed to inform the initial recommendation-making process. It is not updated on a regular basis. For the latest Grade and ETR tables see link below.
WHO Team
Agenda, Policy & Strategy (APS),
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization,
WHO Headquarters (HQ)
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/Sinovac-CoronaVac/background/2021.1
Copyright
